Literature DB >> 16949390

Sex steroid hormone polymorphisms, high-density lipoprotein cholesterol, and apolipoprotein A-1 from the Study of Women's Health Across the Nation (SWAN).

MaryFran R Sowers1, James P Symons, Mary L Jannausch, Jian Chu, Sharon R Kardia.   

Abstract

We evaluated potential associations between single nucleotide polymorphism (SNP) variants in estrogen receptor (ERalpha and ERbeta) genes, high-density lipoprotein (HDL) cholesterol, and apolipoprotein A-1 (apoA-1) concentrations in women of 4 races/ethnicities. Participants included 1,520 African American, Caucasian, Chinese, and Japanese women from the Study of Women's Health Across the Nation (SWAN) who were premenopausal or perimenopausal and who were also enrolled in the SWAN Genetics Study, which collected blood for lipid analyses and carried out lymphocyte transformation from which DNA was extracted and genotyped. We evaluated SNPs from ERalpha and ERbeta genes (ESR1 and ESR2, respectively), including ESR1 rs9340799, ESR1 rs2234693, ESR1 rs728524, ESR1 rs3798577, ESR2 rs1255998, ESR2 rs1256065, and ESR2 rs1256030. The mean HDL cholesterol and apoA-1 values for these women were 1.47 mmol/L and 1.51 g/L, respectively. Japanese women with the ESR1 rs3798577 TC genotype had significantly lower apoA-1 (P=0.02) and HDL cholesterol levels (P=0.03) than did those with the TT genotype. African American women with the ESR1 rs728524 GG genotype had higher HDL cholesterol levels than did women with the AA or AG genotypes (P=0.05). ESR2 rs1256030 and ESR2 rs1256065 genotypes were associated with HDL cholesterol concentrations in Chinese women (P=0.05). Although associations were identified between the ESR1 and ESR2 SNP variants and lipids in these women, these associations were not consistently observed across the 4 racial/ethnic groups, nor were the associations consistently inclusive of both HDL cholesterol and apoA-1. These genetic variants provide limited evidence of associations with lipids that may help explain the cardioprotective effect of premenopausal status in women.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16949390     DOI: 10.1016/j.amjmed.2006.07.008

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  17 in total

1.  Estrogen receptor alpha gene polymorphisms are associated with type 2 diabetes and fasting glucose in male subjects.

Authors:  Reza Meshkani; Hamzeh Saberi; Narges MohammadTaghvaei; Mohammad Amin Tabatabaiefar
Journal:  Mol Cell Biochem       Date:  2011-08-12       Impact factor: 3.396

Review 2.  Genetics of cardiovascular disease: Importance of sex and ethnicity.

Authors:  Stacey J Winham; Mariza de Andrade; Virginia M Miller
Journal:  Atherosclerosis       Date:  2015-03-16       Impact factor: 5.162

3.  Genetic polymorphisms associated with carotid artery intima-media thickness and coronary artery calcification in women of the Kronos Early Estrogen Prevention Study.

Authors:  Virginia M Miller; Tanya M Petterson; Elysia N Jeavons; Abhinita S Lnu; David N Rider; John A Heit; Julie M Cunningham; Gordon S Huggins; Howard N Hodis; Matthew J Budoff; Nanette Santoro; Paul N Hopkins; Rogerio A Lobo; JoAnn E Manson; Frederick Naftolin; Hugh S Taylor; S Mitchell Harman; Mariza de Andrade
Journal:  Physiol Genomics       Date:  2012-11-27       Impact factor: 3.107

4.  Delay discounting, genetic sensitivity, and leukocyte telomere length.

Authors:  Onn-Siong Yim; Xing Zhang; Idan Shalev; Mikhail Monakhov; Songfa Zhong; Ming Hsu; Soo Hong Chew; Poh San Lai; Richard P Ebstein
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-22       Impact factor: 11.205

5.  Sex differences in the associations between lipid levels and incident dementia.

Authors:  Marie-Laure Ancelin; Emmanuelle Ripoche; Anne-Marie Dupuy; Pascale Barberger-Gateau; Sophie Auriacombe; Olivier Rouaud; Claudine Berr; Isabelle Carrière; Karen Ritchie
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

6.  ESR1 polymorphism is associated with plasma lipid and apolipoprotein levels in Caucasians of the Rochester Family Heart Study.

Authors:  Kathy L E Klos; Eric Boerwinkle; Robert E Ferrell; Stephen T Turner; Alanna C Morrison
Journal:  J Lipid Res       Date:  2008-04-30       Impact factor: 5.922

7.  Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS).

Authors:  V M Miller; D M Black; E A Brinton; M J Budoff; M I Cedars; H N Hodis; R A Lobo; J E Manson; G R Merriam; F Naftolin; N Santoro; H S Taylor; S M Harman
Journal:  J Cardiovasc Transl Res       Date:  2009-05-22       Impact factor: 4.132

8.  ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer.

Authors:  Brian Leyland-Jones; Kathryn P Gray; Mark Abramovitz; Mark Bouzyk; Brandon Young; Bradley Long; Roswitha Kammler; Patrizia Dell'Orto; Maria Olivia Biasi; Beat Thürlimann; Vernon Harvey; Patrick Neven; Laurent Arnould; Rudolf Maibach; Karen N Price; Alan S Coates; Aron Goldhirsch; Richard D Gelber; Olivia Pagani; Giuseppe Viale; James M Rae; Meredith M Regan
Journal:  Breast Cancer Res Treat       Date:  2015-11-21       Impact factor: 4.872

9.  Women's Health Initiative Hormone Therapy Trials: New insights on Cardiovascular Disease from Additional Years of Follow up.

Authors:  Virginia M Miller; Joann E Manson
Journal:  Curr Cardiovasc Risk Rep       Date:  2013-06-01

Review 10.  Vascular actions of estrogens: functional implications.

Authors:  Virginia M Miller; Sue P Duckles
Journal:  Pharmacol Rev       Date:  2008-06-25       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.